Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.08
-$0.04-3.57%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -15.12% | 108.47% | 466.07% | -21.05% | 309.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.12% | 108.47% | 466.07% | -21.05% | 309.52% |
| Cost of Revenue | 13.71% | 60.00% | 2,223.08% | 175.00% | 1,490.91% |
| Gross Profit | -75.90% | 200.00% | -65.12% | -73.33% | 59.62% |
| SG&A Expenses | -14.04% | -17.35% | -16.64% | -11.35% | -4.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.11% | -4.22% | 5.55% | -17.47% | -14.17% |
| Operating Income | -24.40% | 7.80% | 7.47% | 17.37% | 25.33% |
| Income Before Tax | -25.52% | 8.60% | 27.02% | 18.28% | 26.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.52% | 8.60% | 27.02% | 18.28% | 26.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.52% | 8.60% | 27.02% | 18.28% | 26.40% |
| EBIT | -24.40% | 7.80% | 7.47% | 17.37% | 25.33% |
| EBITDA | -24.50% | 7.80% | 7.29% | 17.22% | 25.19% |
| EPS Basic | -16.35% | 19.45% | 34.65% | 28.38% | 35.62% |
| Normalized Basic EPS | -16.51% | 19.38% | 18.26% | 28.46% | 35.65% |
| EPS Diluted | -16.35% | 19.45% | 34.65% | 28.38% | 35.62% |
| Normalized Diluted EPS | -16.51% | 19.38% | 18.26% | 28.46% | 35.65% |
| Average Basic Shares Outstanding | 7.90% | 13.42% | 11.65% | 14.14% | 14.33% |
| Average Diluted Shares Outstanding | 7.90% | 13.42% | 11.65% | 14.14% | 14.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |